NYSE:BSXMedical Equipment
How Investors Are Reacting To Boston Scientific (BSX) Recall Wave After Strong Mid‑Year Results
In late July 2026, Boston Scientific reported higher quarterly and half‑year sales and earnings, then in August disclosed multiple voluntary Class II recalls affecting FARASTAR pulsed field ablation generators, FARADRIVE steerable sheaths and the TheraSphere 360 Y‑90 Management Platform software across US and international markets.
While most affected FARASTAR units were limited in number and linked to labeling discrepancies, the FARADRIVE sheath recalls involve hundreds of thousands of...